The Centers for Disease Control and Prevention (CDC) awarded a $2,000,000 Cooperative Agreement under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) to New York University (NYU) School of Medicine. The award, titled "DP24-004, CORE - NYU-CUNY PREVENTION RESEARCH CENTER", has an effective date of September 30, 2024 and a scheduled completion date of September 29, 2029.
Through this Cooperative Agreement, NYU School of Medicine will conduct research, implement interventions, and develop public health awareness strategies focused on preventing and controlling chronic diseases. The project will leverage NYU's expertise as a leading academic medical center to support activities such as epidemiological studies, healthcare-associated infection surveillance, and clinical research on areas like cancer, cardiovascular disease, and neurodegenerative disorders. The funding will also enable NYU to collaborate with other entities, potentially serving as both a prime recipient and subrecipient on multi-site research initiatives.
Generated 1/28/25, 9:51 AM